The upfront lipid-lowering combination therapy of statins and ezetimibe vs statin monotherapy in the reduction of cardiovascular outcomes. A meta-analysis.

被引：0
|
作者：
Banach, M. [1 ]
Jaiswal, V [2 ]
Ang, S. P. [3 ]
Sawhney, A. [4 ]
Deb, N. [5 ]
Penson, P. [6 ]
Toth, P. [7 ]
机构：
[1] Med Univ Lodz, Dept Prevent Cardiol & Lipidol, Lodz, Poland
[2] Larkin Community Hosp, Miami, FL USA
[3] Rutgers Hlth, Internal Med, Community Med Ctr, Newark, NJ USA
[4] Crozer Chester Med Ctr, Dept Internal Med, Upland, PA USA
[5] North Bengal Med Coll, Siliguri, India
[6] Liverpool John Moores Univ, Fac Hlth & Appl Social Sci, Liverpool, England
[7] Johns Hopkins Univ, Sch Med, Dept Cardiol, Baltimore, MD USA
来源：
EUROPEAN HEART JOURNAL | 2024年 / 45卷
关键词：
D O I：
10.1093/eurheartj/ehae666.2873
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Role of non-statin lipid-lowering therapy in coronary atherosclerosis regression: a meta-analysis and meta-regression
    Walter Masson
    Martin Lobo
    Daniel Siniawski
    Graciela Molinero
    Gerardo Masson
    Melina Huerín
    Juan Patricio Nogueira
    Lipids in Health and Disease, 19
  • [22] Comparative Safety and Efficacy of Low/Moderate-Intensity Statin plus Ezetimibe Combination Therapy vs. High-Intensity Statin Monotherapy in Patients with Atherosclerotic Cardiovascular Disease: An Updated Meta-Analysis
    Ishaque Hameed
    Syeda Ayesha Shah
    Ashnah Aijaz
    Hasan Mushahid
    Syed Husain Farhan
    Muhammad Dada
    Adam Bilal Khan
    Reeha Amjad
    Fawad Alvi
    Mustafa Murtaza
    Zaid Zuberi
    Mohammad Hamza
    American Journal of Cardiovascular Drugs, 2024, 24 : 419 - 431
  • [23] Red Yeast Rice and Statin Therapy in Patients with Hypercholesterolemia and the Comorbidities: A Retrospective Cohort Study on Lipid-Lowering Effects and Cardiovascular Outcomes
    Hsueh, Tun-Pin
    Lin, Wan-Ling
    Hu, Wen-Long
    Hung, Yu-Chiang
    AMERICAN JOURNAL OF CHINESE MEDICINE, 2024, 52 (02): : 417 - 432
  • [24] Efficacy of more intensive lipid-lowering therapy on cardiovascular diseases: a systematic review and meta-analysis
    Hsu, Hsin-Yin
    Lin, Chien-Ju
    Lee, Yu-Shan
    Wu, Ting-Hui
    Chien, Kuo-Liong
    BMC CARDIOVASCULAR DISORDERS, 2020, 20 (01)
  • [25] Efficacy of more intensive lipid-lowering therapy on cardiovascular diseases: a systematic review and meta-analysis
    Hsin-Yin Hsu
    Chien-Ju Lin
    Yu-Shan Lee
    Ting-Hui Wu
    Kuo-Liong Chien
    BMC Cardiovascular Disorders, 20
  • [26] Analysis of lipid-lowering therapy and factors affecting regularity of statin intake in patients with cardiovascular disease enrolled in the PROFILE registry
    Gaisenok, Oleg
    Martsevich, Sergey
    Tripkosh, Svetlana
    Lukina, Yulia
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2015, 34 (02) : 111 - 116
  • [27] Lipid-Lowering Therapy and Intracerebral Hemorrhage Risk: Comparative Meta-Analysis of Statins and PCSK9 Inhibitors
    Cuesta, Sanz Borja E.
    Saver, Jeffrey L.
    STROKE, 2021, 52
  • [28] Lipid-Lowering Therapy and Hemorrhagic Stroke Risk Comparative Meta-Analysis of Statins and PCSK9 Inhibitors
    Sanz-Cuesta, Borja E.
    Saver, Jeffrey L.
    STROKE, 2021, 52 (10) : 3142 - 3150
  • [29] The impact of statin-ezetimibe combination therapy versus statin monotherapy on coronary plaque regression in patients with acute coronary syndrome: a meta-analysis
    Pintaningrum, Yusra
    Pramana, Ketut Angga Aditya Putra
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2024, 74 (06) : S23 - S27
  • [30] Lipid-altering efficacy and safety profile of combination therapy with ezetimibe/statin vs. statin monotherapy in patients with and without diabetes: an analysis of pooled data from 27 clinical trials
    Leiter, L. A.
    Betteridge, D. J.
    Farnier, M.
    Guyton, J. R.
    Lin, J.
    Shah, A.
    Johnson-Levonas, A. O.
    Brudi, P.
    DIABETES OBESITY & METABOLISM, 2011, 13 (07): : 615 - 628
12345